ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 34637440.
- Also identified by DOI 10.1371/journal.pmed.1003771 and PMC identifier 8509880.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.
Medical subject headings
- Biomarkers, Tumor
- Circulating Tumor DNA
- Neoadjuvant Therapy
- Neoplasms